Published in Bioresour Technol on November 20, 2009
High levels of β-xylosidase in Thermomyces lanuginosus: potential use for saccharification. Braz J Microbiol (2016) 0.75
Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes. Hum Genet (1991) 12.52
Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet (1994) 10.14
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet (2001) 4.71
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst (2001) 4.14
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res (1994) 3.62
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta (1996) 2.64
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet (1994) 2.52
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene (2001) 2.22
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer (2002) 1.95
Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene (2007) 1.86
Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene (1995) 1.82
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene (2010) 1.69
Germline SDHD mutation in familial phaeochromocytoma. Lancet (2001) 1.62
Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci U S A (1992) 1.56
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene (2010) 1.52
Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res (1992) 1.52
RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene (2007) 1.48
Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci U S A (1996) 1.48
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet (1995) 1.42
Homozygous deletions at 3p12 in breast and lung cancer. Oncogene (1998) 1.42
Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br J Cancer (2004) 1.42
Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet (1994) 1.41
Molecular genetic analysis of the 3p- syndrome. Hum Mol Genet (1994) 1.40
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer (2005) 1.39
Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene (1998) 1.38
Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res (1991) 1.38
Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet (1999) 1.37
Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem (2000) 1.36
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res (2001) 1.35
CALL gene is haploinsufficient in a 3p- syndrome patient. Am J Med Genet (1999) 1.33
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene (2010) 1.29
3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Mol Cell Biol (1996) 1.25
Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer (2008) 1.23
Prevalence of rheumatic heart disease in school children of urban Lahore. Heart (2008) 1.19
Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet (1994) 1.18
Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics (1990) 1.18
WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat (2001) 1.17
RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene (2009) 1.16
Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA (1992) 1.14
Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer (2005) 1.14
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene (2001) 1.12
Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Mol Genet (1993) 1.10
Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet (2003) 1.10
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene (2010) 1.10
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. Br J Cancer (2004) 1.10
MspI and DraI polymorphisms at the ERBA beta locus on chromosome 3p. Nucleic Acids Res (1990) 1.10
Clinical and molecular analyses of deletion 3p25-pter syndrome. Am J Med Genet (1993) 1.10
Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. Genomics (1991) 1.09
Production of ethanol and xylitol from corn cobs by yeasts. Bioresour Technol (2001) 1.09
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis. Oncogene (2010) 1.08
cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol (1994) 1.08
Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem (1998) 1.07
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. Oncogene (2007) 1.06
Detailed mapping of a congenital heart disease gene in chromosome 3p25. J Med Genet (2000) 1.05
Optimization of process variables for minimization of byproduct formation during fermentation of blackstrap molasses to ethanol at industrial scale. Lett Appl Microbiol (2008) 1.04
The DUTT1 gene, a novel NCAM family member is expressed in developing murine neural tissues and has an unusually broad pattern of expression. Mol Cell Neurosci (1998) 1.03
Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Mol Pathol (2000) 1.02
Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res (1999) 1.02
Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis. Mol Med (1995) 1.01
Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet (1991) 0.98
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene (1994) 0.98
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma. J Clin Pathol (2004) 0.97
A genetic linkage map of 96 loci on the short arm of human chromosome 3. Genomics (1992) 0.96
Induction, production, repression, and de-repression of exoglucanase synthesis in Aspergillus niger. Bioresour Technol (2004) 0.96
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer (2004) 0.96
Analysis of CRELD1 as a candidate 3p25 atrioventicular septal defect locus (AVSD2). Clin Genet (2005) 0.95
Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases. Hum Genet (2001) 0.94
Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). Cancer Res (1993) 0.93
An intervention to stop smoking among patients suspected of TB--evaluation of an integrated approach. BMC Public Health (2010) 0.93
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol Pathol (2001) 0.92
Kinetics of enhanced thermostability of an extracellular glucoamylase from Arachniotus sp. Biotechnol Lett (2003) 0.92
Production of cellulases and hemicellulases by an anaerobic mixed culture from lignocellulosic biomass. World J Microbiol Biotechnol (1990) 0.91
Gamma radiation induced mutagenesis in Aspergillus niger to enhance its microbial fermentation activity for industrial enzyme production. Mol Biol Rep (2010) 0.91
Identification of novel VHL targets that are associated with the development of renal cell carcinoma. Oncogene (2006) 0.90
Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am (1993) 0.90
Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers. J Med Genet (1992) 0.90
Genetic basis of renal cell cancer. Important Adv Oncol (1993) 0.88
Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene. J Med Genet (1993) 0.87
Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet (1993) 0.87
TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL). Hum Mol Genet (1993) 0.86
Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. Mol Pathol (2001) 0.85
Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet (2000) 0.85
Rett syndrome and the MECP2 gene. J Med Genet (2001) 0.84
Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum Genet (1996) 0.84
Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. Radiology (2000) 0.83
Kinetics of improved productivity of beta-galactosidase by a cycloheximide-resistant mutant of Kluyveromyces marxianus. Biotechnol Lett (2004) 0.83
Stability and identification of active-site residues of carboxymethylcellulases from Aspergillus niger and Cellulomonas biazotea. Folia Microbiol (Praha) (1997) 0.82
Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. J Med Genet (2002) 0.82
The penetration of ofloxacin into bronchial secretions. J Antimicrob Chemother (1988) 0.82
Kinetics of enhanced ethanol productivity using raw starch hydrolyzing glucoamylase from Aspergillus niger mutant produced in solid state fermentation. Lett Appl Microbiol (2004) 0.81
Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med (1992) 0.81
Relationship between indices of adiposity obtained by peripheral quantitative computed tomography and dual-energy X-ray absorptiometry in pre-pubertal children. Ann Hum Biol (2009) 0.80
Haemolytic uraemic syndrome in children. J Pak Med Assoc (1991) 0.80
Developmental delay and the methyl binding genes. J Med Genet (2003) 0.80
One-megabase yeast artificial chromosome and 400-kilobase cosmid-phage contigs containing the von Hippel-Lindau tumor suppressor and Ca(2+)-transporting adenosine triphosphatase isoform 2 genes. Cancer Res (1994) 0.79
Activity and thermostability of carboxymethylcellulase from Aspergillus niger is strongly influenced by noncovalently attached polysaccharides. World J Microbiol Biotechnol (1996) 0.79